Risk and Cost Associated With Drug–Drug Interactions Among Aging HIV Patients Receiving Combined Antiretroviral Therapy in France

Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy

(2018) Krista J. Siefried et al.   AIDS

Increased dolutegravir peak concentrations in people living with HIV aged 60 and over and analysis of sleep quality and cognition

(2018) Emilie R Elliot et al.   CLINICAL INFECTIOUS DISEASES

Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patients

(2018) Clotilde Allavena et al.   PLoS One

Frequency and severity of potential drug interactions in a cohort of HIV-infected patients Identified through a Multidisciplinary team

(2017) E. Molas et al.   HIV CLINICAL TRIALS

Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study

(2017) Silvia Nozza et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

We Are Using Too Many PPIs and We Need to Stop: A European Perspective

(2016) Angel Lanas   AMERICAN JOURNAL OF GASTROENTEROLOGY

Comparing the Frequencies of Contraindicated Drug-Drug Interactions Between Differing Antiretroviral Regimens in HIV-Infected Patients

(2016) Bernadette Jakeman et al.   ANNALS OF PHARMACOTHERAPY

Higher rates of neuropsychiatric adverse events leading to dolutegravir discontinuation in women and older patients

(2016) C Hoffmann et al.   HIV MEDICINE

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults

(2016) Huldrych F. Günthard et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Cobicistat versus ritonavir boosting and differences in the drug–drug interaction profiles with co-medications

(2016) Catia Marzolini et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Frailty in HIV: Epidemiology, Biology, Measurement, Interventions, and Research Needs

(2016) Damani A. Piggott et al.   Current HIV/AIDS Reports

American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults

(2015)   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Association of Age With Polypharmacy and Risk of Drug Interactions With Antiretroviral Medications in HIV-Positive Patients

(2014) Alice Tseng et al.   ANNALS OF PHARMACOTHERAPY

Identification of potential clinically significant drug interactions in HIV-infected patients: a comprehensive therapeutic approach

(2014) C Iniesta-Navalón et al.   HIV MEDICINE

Polypharmacy and Risk of Antiretroviral Drug Interactions Among the Aging HIV-Infected Population

(2013) Carol Holtzman et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada

(2013) Hasina Samji et al.   PLoS One

Pharmacologic Boosting of Atazanavir in Maintenance HIV-1 Therapy: The COREYA Propensity-Score Adjusted Study

(2012) Laurent Hocqueloux et al.   PLoS One

Premature Age-Related Comorbidities Among HIV-Infected Persons Compared With the General Population

(2011) G. Guaraldi et al.   CLINICAL INFECTIOUS DISEASES

Recognition of Risk for Clinically Significant Drug Interactions among HIV‐Infected Patients Receiving Antiretroviral Therapy

(2010) John G. Evans‐Jones et al.   CLINICAL INFECTIOUS DISEASES

The Cost and Incidence of Prescribing Errors Among Privately Insured HIV Patients

(2009) Fred J. Hellinger et al.   PHARMACOECONOMICS

Aging and Infectious Diseases: Workshop on HIV Infection and Aging: What Is Known and Future Research Directions

(2008) Rita B. Effros et al.   CLINICAL INFECTIOUS DISEASES

Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies

(2008)   LANCET